• 1
    Cramer JA. Quality of life for people with epilepsy. Neurol Clin 1994; 12:113.
  • 2
    Cramer JA. Quality of life assessments in epilepsy. In: SpilkerB, ed. Quality of i f e and pharmacoeconomies in clinical trials. Philadelphia : Lippincott-Raven Publishers, 1996:90918.
  • 3
    World Health Organization. World Health Organization: The first 10 years of the World Health Organization. Geneva , Switzerland : World Health Organization, 1958.
  • 4
    Devinsky O, Vickrey BG, Cramer JA, Perrine K, Hermann B, Meador K, Hays RD. Development of the quality of life in epilepsy (QOLIE) inventory. Epilepsia 1995;36:1089104.
  • 5
    Vickrey BG, Hays RD, Graber J, Rausch R, Engel J, Brook RH. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Cure 1992;30:299319.
  • 6
    Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure for epilepsy. Epilepsy Res 1993;16:6581.
  • 7
    Acquadro C, Jambon B, Ellis D, Marquis P. Language and translation issues. In: SpilkerB, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. New York : Lippincott-Raven Publishers, 1995:57586.
  • 8
    Hays RD, Sherbourne C, Mazel E. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:21227.
  • 9
    Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): 1. Conceptual framework and item selection. MedCare 1992;30:47383.
  • 10
    Cramer JA, Smith DB, Mattson RH, Delgado-Escueta AV, Collins JF, and the VA Epilepsy Cooperative Study Group A method of quantification for the evaluation of antiepileptic drug therapy. Neurology 1983;33(suppl 1):2637.
  • 11
    Perrine K, Hermann BP, Meador KJ, Vickrey BG, Cramer JA, Hays RD, Devinsky O. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995;52:9971003.
  • 12
    McNair D, Lorr M, Droppleman L. POMS; Profile of Mood States. San Diego , CA : EITS/Educational and Industrial Testing Service, 1992.
  • 13
    MAPI Research Institute. Cultural adaptation of the QOLIE-31 into UK-English, Italian, Spanish, Canadian French, French, German, Danish, und Swedish. Lyon : MAPI, August, 1966.
  • 14
    Vickrey BG, Perrine KR, Hays RD, et al. Quality of life in epilepsy QOLIE-31 (version 1.0); scoring manual and patient inventory. Santa Monica , CA : RAND, 1993.
  • 15
    Brazier J, Jones J, Kind P. Testing the validity of the Euroquol and comparing it with the SF-36 Health Survey questionnaire. QOL Res 1993:2:16980.
  • 16
    Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality of life measurement. Epilepsia 1997;38:2336.
  • 17
    Cramer JA, Perrine K, Devinsky O, Meador K. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia 1996;37:57782.
  • 18
    Cramer JA, Devinsky O, Westbrook L, et al. Adaptation of an epilepsy quality of life instrument for adolescents. Epilepsia 1995; 36(suppl 4):93.
  • 19
    Mosier CI. On the reliability of a weighted composite. Psychometrika 1943;8:1618.
  • 20
    Andrews FM, Withey SB. Social indicators of well-being. New York : Plenum Press: 1976.
  • 21
    Hadorn D, Hays RD. Multitrait-multimethod analysis of health-related quality of life preferences. Med Care 1991; 29:82940.
  • 22
    Stewart AL, Sherbourne CD, Hays RD, et al. Summary and discussion of MOS measures. In: StewartAL, WareJE, eds. Measuring functioning and well-being: the medical outcomes study approach. Durham , NC : Duke University Press, 1992:299319.
  • 23
    Nelson EC, Landgraf JM, Hays RD, Wasson JH, Kirk JW. The functional status of patients: how can it be measured in physicians' offices Med Care 1990:28:111126.